Results 281 to 290 of about 9,795,905 (347)

Bioactive Peptides and Probiotic Bacteria: Modulators of Human Health. [PDF]

Foods
Wang Q, Zheng Y.
europepmc   +1 more source

Current Status of Human Resources at Commune Health Centers in Binh Duong Province According to National Standards for Commune Health and Factors Related to Public Satisfaction, 2023-2024

Nguyen Binh Phuong, Nguyễn Phi Long
openalex   +1 more source

EVALUATION OF EPIDENMIOLOGICAL SITUATION CONCERNING TRICHINELLOSIS FROM THE ASPECT OF HUMAN HEALTH RISK [PDF]

, 2009
Teresa Kłapeć, M Stroczyńska-Sikorska
openalex  

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Edible evolution: the significance of food additives in shaping human health. [PDF]

Front Nutr
Erickson A, Bellampalli S, Beyder A.
europepmc   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Radiation and Human Health

American Journal of Public Health and the Nations Health, 1957
openaire   +3 more sources

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Research and Industry for Human Health Enabled by Detergent Chemistry. [PDF]

Chempluschem
Urner LH.
europepmc   +1 more source